These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 15570541)

  • 41. The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia.
    David SR; Taylor CC; Kinon BJ; Breier A
    Clin Ther; 2000 Sep; 22(9):1085-96. PubMed ID: 11048906
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination alprazolam-neuroleptic treatment of the positive and negative symptoms of schizophrenia.
    Wolkowitz OM; Pickar D; Doran AR; Breier A; Tarell J; Paul SM
    Am J Psychiatry; 1986 Jan; 143(1):85-7. PubMed ID: 2867690
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study.
    Wang X; Savage R; Borisov A; Rosenberg J; Woolwine B; Tucker M; May R; Feldman J; Nemeroff CB; Miller AH
    J Psychiatr Res; 2006 Oct; 40(7):669-76. PubMed ID: 16762371
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Performance of diadochokinetic movements in schizophrenic patients.
    Putzhammer A; Perfahl M; Pfeiff L; Ibach B; Johann M; Zitzelsberger U; Hajak G
    Schizophr Res; 2005 Nov; 79(2-3):271-80. PubMed ID: 15987669
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuroleptic malignant syndrome.
    Knezevic W; Mastaglia FL; Lefroy RB; Fisher A
    Med J Aust; 1984 Jan; 140(1):28-30. PubMed ID: 6146918
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative EEG in schizophrenic patients before and during pharmacotherapy.
    Begić D; Hotujac L; Jokić-Begić N
    Neuropsychobiology; 2000; 41(3):166-70. PubMed ID: 10754432
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A multidimensional (pharmacokinetic and clinical-biological) approach to neuroleptic response in schizophrenia. With particular reference to drug resistance.
    Altamura AC
    Schizophr Res; 1993 Jan; 8(3):187-98. PubMed ID: 8094628
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heatstroke in a chronic schizophrenic patient treated with high-potency neuroleptics.
    Lazarus A
    Gen Hosp Psychiatry; 1985 Oct; 7(4):361-3. PubMed ID: 2866145
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Information processing and neuroleptic response in acute and stabilized schizophrenic patients.
    Marder SR; Asarnow RF; Van Putten T
    Psychiatry Res; 1984 Sep; 13(1):41-9. PubMed ID: 6151203
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuroleptic drug effect on plasma dopamine-beta-hydroxylase in schizophrenia.
    Baron M; Gruen R; Levitt M; Kane J
    Neuropsychobiology; 1982; 8(6):312-4. PubMed ID: 6131392
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Certain neuroleptics reduce bone mineralization in schizophrenic patients.
    Higuchi T; Komoda T; Sugishita M; Yamazaki J; Miura M; Sakagishi Y; Yamauchi T
    Neuropsychobiology; 1987; 18(4):185-8. PubMed ID: 2900482
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of obesity in patients receiving depot antipsychotics.
    Silverstone T; Smith G; Goodall E
    Br J Psychiatry; 1988 Aug; 153():214-7. PubMed ID: 2908236
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Catatonic reactions to high-potency neuroleptic drugs.
    Gelenberg AJ; Mandel MR
    Arch Gen Psychiatry; 1977 Aug; 34(8):947-50. PubMed ID: 889419
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic factors in the response to neuroleptics in schizophrenia: a psychopharmacogenetic study.
    Galdi J; Rieder RO; Silber D; Bonato RR
    Psychol Med; 1981 Nov; 11(4):713-28. PubMed ID: 6119718
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuroleptic-induced seizures. An in vitro technique for assessing relative risk.
    Oliver AP; Luchins DJ; Wyatt RJ
    Arch Gen Psychiatry; 1982 Feb; 39(2):206-9. PubMed ID: 6175290
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intolerance to neuroleptics and susceptibility for malignant hyperthermia in a patient with proximal myotonic myopathy (PROMM) and schizophrenia.
    Schneider C; Pedrosa Gil F; Schneider M; Anetseder M; Kress W; Müller CR
    Neuromuscul Disord; 2002 Jan; 12(1):31-5. PubMed ID: 11731282
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cellular immunity in schizophrenic patients before and during neuroleptic treatment.
    Müller N; Ackenheil M; Hofschuster E; Mempel W; Eckstein R
    Psychiatry Res; 1991 May; 37(2):147-60. PubMed ID: 1678892
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disturbed behavior induced by high-dose antipsychotic drugs.
    Barnes TR; Bridges PK
    Br Med J; 1980 Jul; 281(6235):274-5. PubMed ID: 7427243
    [No Abstract]   [Full Text] [Related]  

  • 59. Neuroleptic malignant syndrome.
    Bates I; Courtenay-Evans RJ
    Br Med J (Clin Res Ed); 1984 Jun; 288(6434):1913. PubMed ID: 6428599
    [No Abstract]   [Full Text] [Related]  

  • 60. Self-cannibalism: an unusual case of self-mutilation.
    de Moore GM; Clement M
    Aust N Z J Psychiatry; 2006 Oct; 40(10):937. PubMed ID: 16959023
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.